ARCHIVES

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

This article is from The Cancer Letter archive.

Vol. 24 No. 41 | October 30, 1998

Download PDF Visit The Full Archive

Related Articles

Avastin Loses Indication for Breast Cancer

November 18, 2011

Program Announcements

August 3, 2001

Rays Of Hope Candlelight Vigil Scheduled For Oct. 6.

September 8, 2000

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

NAS Report Advises Candidates on Filling Key Science Positions.

October 31, 2008